Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00707564

Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications

A Randomized, Self-Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
HemCon Medical Technologies, Inc · Industry
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the HemCon Dental Dressing is effective in stopping bleeding during dental surgeries in patients taking anticoagulant medications.

Detailed description

As the HemCon® Dental Dressing has been FDA cleared for use as a physical barrier for temporary protection of oral mucosal tissue and to provide pain relief, the proposed study will further investigate the safety and efficacy of hemostasis of the dressing for use in dental surgical procedures that do not require primary closure (suturing) such as tooth extractions. This protocol will specifically research the safety and efficacy of hemostasis within a population of subjects taking anticoagulant medications.

Conditions

Interventions

TypeNameDescription
DEVICEHemCon Dental DressingThe HemCon Dental Dressing is an oral wound dressing made of chitosan
DEVICEGauze with pressureGauze with pressure

Timeline

Start date
2008-07-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2008-07-01
Last updated
2012-09-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00707564. Inclusion in this directory is not an endorsement.